Peripheral Arterial Disease in People with Diabetes

Diabetes Care

Volumn 26, Issue 12, 2003, Pages 3333-3341

  Clark, Nathaniel ^a  

^a AMERICAN DIABETES ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; RAMIPRIL; SIMVASTATIN;

ANAMNESIS; ANATOMY; ARTERY DISEASE; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR RISK; CELL FUNCTION; CIGARETTE SMOKING; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; DEBRIDEMENT; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG EFFECT; DRUG TOLERABILITY; DYSLIPIDEMIA; ECHOGRAPHY; ENDOTHELIUM CELL; EPIDEMIOLOGICAL DATA; EXERCISE; FOOT DISEASE; FUNCTION TEST; GLUCOSE BLOOD LEVEL; HEALTH CARE; HUMAN; HYPERTENSION; INFECTION; INFLAMMATION; ISCHEMIA; LABORATORY TEST; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL RECORD; META ANALYSIS; PHYSICAL EXAMINATION; PULSE RATE; REVASCULARIZATION; REVIEW; SHOE; SMOKING CESSATION; SMOOTH MUSCLE FIBER; THROMBOCYTE; TREADMILL; VASCULAR SMOOTH MUSCLE; WOUND DRESSING;

ARTERIAL OCCLUSIVE DISEASES; ARTERIOSCLEROSIS; DIABETIC ANGIOPATHIES; DIABETIC FOOT; EXERCISE; EXERCISE TEST; HUMANS; INCIDENCE; PERIPHERAL VASCULAR DISEASES; RISK FACTORS; UNITED STATES; VASCULAR SURGICAL PROCEDURES;

EID: 0344844381     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.12.3333     Document Type: Review

References (37)

1. Murabito JM, D'Agostino RB, Silbershatz H, Wilson WF: Intermittent claudication: a risk profile from the Framingham Heart Study. Circulation 96:44-49, 1997
2. Hiatt WR: Medical treatment of peripheral arterial disease and claudication. N Engl J Med 344:1608-1621, 2001
3. Criqui MH: Peripheral arterial disease: epidemiological aspects. Vascular Medicine 6 (Suppl. 1):3-7, 2001
4. Bernstein EF, Fronek A: Current status of non-invasive tests in the diagnosis of peripheral arterial disease. Surg Clin North Am 62:473-487, 1982
5. Elhadd TA, Robb R, Jung RT, Stonebridge PA, Belch JJF: Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic. Practical Diabetes Int 16:163-166, 1999
6. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286:1317-1324, 2001
7. Weitz JI, Byrne J, Clagett GP, Farkouh ME, Porter JM, Sackett DL, Strandness DE Jr, Taylor LM: Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 94:3026-3049, 1996
8. Dormandy JA, Rutherford RB: Management of peripheral arterial disease (PAD): TASC Working Group: TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 31:S1-S296, 2000
9. Dolan NC, Liu K, Criqui MH, Greenland P, Guralnik JM, Chan C, Schneider JR, Mandapat AL, Martin G, McDermott MM: Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care 25:113-120, 2002
10. McDaniel MD, Cronenwett JL: Basic data related to the natural history of intermittent claudication. Ann Vasc Surg 3:273-277, 1989
11. Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287:2570-2581, 2002
12. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97:425-428, 1998
13. Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D, Chrzan JS, DeGirolami U, LoGerfo FW, Freeman R: Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 47:457-463, 1998
14. Steinberg HO, Baron AD: Vascular function, insulin resistance and fatty acids. Diabetologia 45:623-634, 2002
15. Tsao PS, Wang B, Buitrago R, Shyy JY, Cooke JP: Nitric oxide regulates monocyte chemotactic protein-1. Circulation 96:934-940, 1997
16. Geng YJ, Libby P: Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol 22:1370-1380, 2002
17. Schneider DL, Sobel BE: Diabetes and thrombosis. In Diabetes and Cardiovascular Disease. Johnstone MT, Veves A, Eds. Totowa, NJ, Humana Press, 2001
18. American Diabetes Association: Preventive foot care in people with diabetes (Position Statement). Diabetes Care 26 (Suppl. 1):S78-S79, 2003
19. Strandness DE Jr, Bell JW: Peripheral vascular disease: diagnosis and evaluation using a mercury strain gauge. Ann Surg 161 (Suppl. 4):1-35, 1965
20. Lassila R, Lepantalo M: Cigarette smoking and the outcome after lower limb arterial surgery. Acta Chir Scand 154:635-640, 1988
21. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
22. Stokes J, Kannel WB, Wolf PA, Cupples LA, D'Agostino RB: The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation 75:V65-V73, 1987
23. UK Prospective Diabetes Study (UKPDS) Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 317:703-713, 1998
24. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:145-153, 2000
25. Leng GC, Price JF, Jepson RG: Lipid-lowering for lower limb atherosclerosis (Cochrane Review). Cochrane Database Syst Rev 2:CD000123, 2000
26. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389, 1994
27. Kjekshus J, Pedersen TR: Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S). Am J Cardiol 76:64C-68C, 1995
28. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7-22, 2002
29. Antiplatelet Trialists' Collaboration: Collaborative overview of randomised trials of antiplatelet therapy. I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 308:81-106, 1994
30. American Diabetes Association: Aspirin therapy in diabetes (Position Statement). Diabetes Care 26 (Suppl. 1):S87-S88, 2003
31. CAPRIE Steering Committee: A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329-1339, 1996
32. Larsen OA, Lassen NA: Effect of daily muscular exercise in patients with intermittent claudication. Lancet 2:1093-1096, 1966
33. Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication (Cochrane Review). Cochrane Database Syst Rev 2: CD000990, 2000
34. Regensteiner JG, Ware JE Jr, McCarthy WJ, Zhang P, Forbes WP, Heckman J, Hiatt WR: Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatr Soc 50:1939-1946, 2002
35. Dawson DL, Cutler BS, Hiatt WR, Hobson RW 2nd, Martin JD, Bortey EB, Forbes WP, Strandness DE: A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med 109:523-530, 2000
36. Kannel WB, Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk 1:3333-3339, 1994
37. American Diabetes Association: Diabetic foot wound care (Consensus Statement). Diabetes Care 21:1354-1360, 1999